Inter-epidemic Rift Valley fever virus infection incidence and risks for zoonotic spillover in northern Tanzania.


Journal

PLoS neglected tropical diseases
ISSN: 1935-2735
Titre abrégé: PLoS Negl Trop Dis
Pays: United States
ID NLM: 101291488

Informations de publication

Date de publication:
10 2022
Historique:
received: 08 02 2022
accepted: 06 10 2022
revised: 15 11 2022
pubmed: 29 10 2022
medline: 19 11 2022
entrez: 28 10 2022
Statut: epublish

Résumé

Rift Valley fever virus (RVFV) is a mosquito-borne pathogen that has caused epidemics involving people and animals across Africa and the Arabian Peninsula. A number of studies have found evidence for the circulation of RVFV among livestock between these epidemics but the population-level incidence of infection during this inter-epidemic period (IEP) is rarely reported. General force of infection (FOI) models were applied to age-adjusted cross-sectional serological data to reconstruct the annual FOI and population-level incidence of RVFV infection among cattle, goats, and sheep in northern Tanzania from 2009 through 2015, a period without reported Rift Valley fever (RVF) cases in people or animals. To evaluate the potential for zoonotic RVFV spillover during this period, the relationship between village-level livestock RVFV FOI and human RVFV seropositivity was quantified using multi-level logistic regression. The predicted average annual incidence was 72 (95% Credible Interval [CrI] 63, 81) RVFV infections per 10,000 animals and 96 (95% CrI 81, 113), 79 (95% CrI 62, 98), and 39 (95% CrI 28, 52) per 10,000 cattle, sheep, and goats, respectively. There was variation in transmission intensity between study villages, with the highest estimated village-level FOI 2.49% (95% CrI 1.89, 3.23) and the lowest 0.12% (95% CrI 0.02, 0.43). The human RVFV seroprevalence was 8.2% (95% Confidence Interval 6.2, 10.9). Human seropositivity was strongly associated with the village-level FOI in livestock, with the odds of seropositivity in an individual person increasing by around 1.2 times (95% CrI 1.1, 1.3) for each additional annual RVFV seroconversion per 1,000 animals. A history of raw milk consumption was also positively associated with human seropositivity. RVFV has circulated at apparently low levels among livestock in northern Tanzania in the period since the last reported epidemic. Although our data do not allow us to confirm human RVFV infections during the IEP, a strong association between human seropositivity and the FOI in cattle, goats, and sheep supports the hypothesis that RVFV circulation among livestock during the IEP poses a risk for undetected zoonotic spillover in northern Tanzania. We provide further evidence for the likely role of raw milk consumption in RVFV transmission from animals to people.

Identifiants

pubmed: 36306281
doi: 10.1371/journal.pntd.0010871
pii: PNTD-D-22-00164
pmc: PMC9665400
doi:

Substances chimiques

Antibodies, Viral 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0010871

Subventions

Organisme : Biotechnology and Biological Sciences Research Council
ID : BB/L018926/1
Pays : United Kingdom
Organisme : Biotechnology and Biological Sciences Research Council
ID : BB/N503563/1
Pays : United Kingdom
Organisme : Biotechnology and Biological Sciences Research Council
ID : BB/J010367/1
Pays : United Kingdom
Organisme : Biotechnology and Biological Sciences Research Council
ID : BB/L017679/1
Pays : United Kingdom
Organisme : Biotechnology and Biological Sciences Research Council
ID : BB/J010367
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_12014/10
Pays : United Kingdom

Informations de copyright

Copyright: © 2022 de Glanville et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Onderstepoort J Vet Res. 2014 Apr 23;81(2):E1-5
pubmed: 25005550
Am J Trop Med Hyg. 2007 May;76(5):795-800
pubmed: 17488893
Proc Natl Acad Sci U S A. 2018 Jul 31;115(31):E7448-E7456
pubmed: 30021855
Vector Borne Zoonotic Dis. 2017 Feb;17(2):141-146
pubmed: 27929928
Transbound Emerg Dis. 2015 Feb;62(1):13-23
pubmed: 23551913
PLoS Negl Trop Dis. 2013 Aug 08;7(8):e2356
pubmed: 23951376
Trans R Soc Trop Med Hyg. 2022 Nov 1;116(11):1082-1090
pubmed: 36040309
Virology. 2016 Feb;489:128-40
pubmed: 26748334
PLoS Negl Trop Dis. 2019 Mar 20;13(3):e0007258
pubmed: 30893298
Front Vet Sci. 2019 Aug 14;6:258
pubmed: 31475162
Infect Ecol Epidemiol. 2015 Nov 18;5:30025
pubmed: 26584830
PLoS Negl Trop Dis. 2016 Dec 21;10(12):e0005167
pubmed: 28002417
Trop Med Int Health. 2014 Dec;19(12):1420-9
pubmed: 25252137
Front Vet Sci. 2022 Jun 14;9:897481
pubmed: 35774979
J Int AIDS Soc. 2012 Mar 14;15(1):14
pubmed: 22417328
Int J Epidemiol. 1997 Feb;26(1):224-7
pubmed: 9126524
PLoS Negl Trop Dis. 2019 May 3;13(5):e0007296
pubmed: 31050673
Vaccine. 2014 Apr 25;32(20):2337-44
pubmed: 24631070
J Anim Breed Genet. 2017 Dec;134(6):531-544
pubmed: 28345262
PLoS Negl Trop Dis. 2021 Aug 24;15(8):e0009630
pubmed: 34428205
J Epidemiol Community Health. 2005 Jun;59(6):443-9
pubmed: 15911637
Parasit Vectors. 2016 Mar 31;9:184
pubmed: 27036889
Epidemiol Infect. 2018 Dec 05;147:e67
pubmed: 30516123
Annu Rev Entomol. 2016;61:395-415
pubmed: 26982443
Ecology. 2006 Sep;87(9):2356-65
pubmed: 16995636
J Infect Dis. 1984 Mar;149(3):311-9
pubmed: 6371153
Am J Trop Med Hyg. 2019 Aug;101(2):459-466
pubmed: 31219026
Emerg Infect Dis. 2008 Aug;14(8):1240-6
pubmed: 18680647
Zoonoses Public Health. 2020 Aug;67(5):496-505
pubmed: 32374085
Pathogens. 2021 Jun 05;10(6):
pubmed: 34198898
Am J Trop Med Hyg. 2011 Apr;84(4):641-6
pubmed: 21460024
Sci Rep. 2022 Jul 8;12(1):11669
pubmed: 35803982
J Am Mosq Control Assoc. 1985 Mar;1(1):93-5
pubmed: 2906661
Epidemiol Infect. 2010 Jun;138(6):802-12
pubmed: 19765352
PLoS Negl Trop Dis. 2020 Jul 20;14(7):e0008061
pubmed: 32687540
Emerg Infect Dis. 2005 Nov;11(11):1693-700
pubmed: 16318720
iScience. 2020 Oct 14;23(11):101669
pubmed: 33134899
PLoS Negl Trop Dis. 2015 Feb 27;9(2):e0003536
pubmed: 25723502
Antiviral Res. 2020 Feb;174:104692
pubmed: 31870761
Anim Genet. 2012 Feb;43(1):63-71
pubmed: 22221026
Res Vet Sci. 1967 Oct;8(4):406-14
pubmed: 6070723
PLoS Negl Trop Dis. 2018 Nov 12;12(11):e0006931
pubmed: 30418975
PLoS One. 2020 Dec 30;15(12):e0229478
pubmed: 33378382
PLoS Negl Trop Dis. 2011 Dec;5(12):e1423
pubmed: 22206026
Glob Health Action. 2021 Jan 1;14(1):1957554
pubmed: 34415237
Front Vet Sci. 2019 Sep 26;6:327
pubmed: 31681800
PLoS One. 2014 Feb 25;9(2):e88897
pubmed: 24586433
Environ Health. 2013 Oct 04;12(1):85
pubmed: 24093917
PLoS Negl Trop Dis. 2012;6(3):e1557
pubmed: 22479657
Tanzan J Health Res. 2011 Dec;13(5 Suppl 1):305-18
pubmed: 26591986
PLoS Negl Trop Dis. 2018 Jul 23;12(7):e0006627
pubmed: 30036382
J Virol Methods. 2013 Jan;187(1):177-81
pubmed: 23022325
Vet Rec. 2005 Nov 12;157(20):619-23
pubmed: 16284330
BMC Infect Dis. 2018 Jun 14;18(1):276
pubmed: 29898686
PLoS Negl Trop Dis. 2021 Jan 25;15(1):e0008100
pubmed: 33493173
Sci Rep. 2017 Jan 04;7:39870
pubmed: 28051125
Viruses. 2020 Feb 07;12(2):
pubmed: 32046120
Transbound Emerg Dis. 2018 Feb;65(1):e55-e62
pubmed: 28710814

Auteurs

William A de Glanville (WA)

School of Biodiversity, One Health, and Veterinary Medicine, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom.
University of Global Health Equity, Kigali, Rwanda.

James M Nyarobi (JM)

School of Biodiversity, One Health, and Veterinary Medicine, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom.
Nelson Mandela African Institution of Science and Technology, Arusha, Tanzania.

Tito Kibona (T)

Nelson Mandela African Institution of Science and Technology, Arusha, Tanzania.

Jo E B Halliday (JEB)

School of Biodiversity, One Health, and Veterinary Medicine, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom.

Kate M Thomas (KM)

Centre for International Health, University of Otago, Dunedin, New Zealand.
Kilimanjaro Clinical Research Institute, Moshi, United Republic of Tanzania.

Kathryn J Allan (KJ)

School of Biodiversity, One Health, and Veterinary Medicine, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom.

Paul C D Johnson (PCD)

School of Biodiversity, One Health, and Veterinary Medicine, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom.

Alicia Davis (A)

School of Social and Political Sciences, University of Glasgow, Glasgow, United Kingdom.

Felix Lankester (F)

Paul G. Allen School for Global Health, Washington State University, Pullman, Washington, United States of America.
Global Animal Health Tanzania, Arusha, Tanzania.

John R Claxton (JR)

School of Biodiversity, One Health, and Veterinary Medicine, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom.

Melinda K Rostal (MK)

School of Biodiversity, One Health, and Veterinary Medicine, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom.
EcoHealth Alliance, New York, New York, United States of America.

Ryan W Carter (RW)

School of Biodiversity, One Health, and Veterinary Medicine, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom.

Rosanne M F de Jong (RMF)

School of Biodiversity, One Health, and Veterinary Medicine, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom.

Matthew P Rubach (MP)

Division of Infectious Diseases and International Health, Duke University Medical Center, Durham, North Carolina, United States of America.
Duke Global Health Institute, Duke University, Durham, North Carolina, United States of America.
Programme in Emerging Infectious Diseases, Duke-National University of Singapore, Singapore.

John A Crump (JA)

Centre for International Health, University of Otago, Dunedin, New Zealand.
Division of Infectious Diseases and International Health, Duke University Medical Center, Durham, North Carolina, United States of America.
Duke Global Health Institute, Duke University, Durham, North Carolina, United States of America.
Kilimanjaro Christian Medical University College, Tumaini University, Moshi, Tanzania.

Blandina T Mmbaga (BT)

Kilimanjaro Clinical Research Institute, Moshi, United Republic of Tanzania.
Duke Global Health Institute, Duke University, Durham, North Carolina, United States of America.
Kilimanjaro Christian Medical University College, Tumaini University, Moshi, Tanzania.

Obed M Nyasebwa (OM)

Ministry of Livestock and Fisheries, Dodoma, United Republic of Tanzania.

Emanuel S Swai (ES)

Ministry of Livestock and Fisheries, Dodoma, United Republic of Tanzania.

Brian Willett (B)

MRC University of Glasgow Centre for Virus Research, Glasgow, United Kingdom.

Sarah Cleaveland (S)

School of Biodiversity, One Health, and Veterinary Medicine, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH